Kestra Advisory Services’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.7M | Sell |
164,963
-22,267
| -12% | -$2.39M | 0.09% | 229 |
|
|
2025
Q1 | $18.9M | Sell |
187,230
-29,366
| -14% | -$2.96M | 0.09% | 192 |
|
|
2024
Q4 | $19.3M | Buy |
216,596
+1,784
| +0.8% | +$159K | 0.11% | 190 |
|
|
2024
Q3 | $18M | Sell |
214,812
-30,912
| -13% | -$2.59M | 0.1% | 216 |
|
|
2024
Q2 | $18.9M | Sell |
245,724
-11,361
| -4% | -$875K | 0.11% | 205 |
|
|
2024
Q1 | $17.6M | Buy |
257,085
+4,377
| +2% | +$300K | 0.12% | 170 |
|
|
2023
Q4 | $14.6M | Sell |
252,708
-13,842
| -5% | -$800K | 0.12% | 186 |
|
|
2023
Q3 | $14.1M | Buy |
266,550
+142,567
| +115% | +$7.53M | 0.14% | 160 |
|
|
2023
Q2 | $6.71M | Sell |
123,983
-27,929
| -18% | -$1.51M | 0.07% | 298 |
|
|
2023
Q1 | $7.6M | Sell |
151,912
-12,341
| -8% | -$617K | 0.08% | 257 |
|
|
2022
Q4 | $7.6M | Sell |
164,253
-196,481
| -54% | -$9.09M | 0.07% | 312 |
|
|
2022
Q3 | $14M | Buy |
360,734
+190,874
| +112% | +$7.39M | 0.15% | 155 |
|
|
2022
Q2 | $6.33M | Buy |
169,860
+19,857
| +13% | +$740K | 0.07% | 305 |
|
|
2022
Q1 | $6.64M | Buy |
150,003
+37,625
| +33% | +$1.67M | 0.07% | 304 |
|
|
2021
Q4 | $4.77M | Sell |
112,378
-1,751
| -2% | -$74.4K | 0.05% | 383 |
|
|
2021
Q3 | $4.95M | Buy |
114,129
+4,433
| +4% | +$192K | 0.05% | 392 |
|
|
2021
Q2 | $4.69M | Buy |
109,696
+5,751
| +6% | +$246K | 0.05% | 373 |
|
|
2021
Q1 | $4.02M | Sell |
103,945
-150,537
| -59% | -$5.82M | 0.05% | 382 |
|
|
2020
Q4 | $9.05M | Buy |
254,482
+146,911
| +137% | +$5.22M | 0.1% | 219 |
|
|
2020
Q3 | $4.2M | Buy |
+107,571
| New | +$4.2M | 0.08% | 266 |
|